EMEA London Office Lease Signed

7 November 1994

Late last month Fernand Sauer, executive director of the European Medicines Evaluation Agency, signed the agreement for lease for the new EMEA offices in London's Docklands, at 7 Westferry Circus, Canary Wharf, London E14 4HB. Agency staff are in fact now in temporary accommodation, also at Canary Wharf, while the offices are fitted out, and they expect to move into Westferry Circus when they take up their responsibilities on January 1, 1995.

- Growth in UK health care exports is at its highest for five years, UK Health Minister Gerald Malone has announced. For example, between 1992 and 1993 exports of medical equipment to Thailand more than doubled, he said, and exports to Malaysia rose 50%. In 1992, exports of pharmaceuticals and medical equipment formed 4.3% of all UK visible exports, earning a surplus trade balance of nearly L2 billion ($3.2 billion), he added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight